APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nicergoline

Compare research editions
View pricing & licenses

Selected research

Industry Research

Nicergoline Industry Research Report 2026

29 December 2025137 pages

Choose your research edition.

Industry ResearchNicergoline Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Nicergoline Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Nicergoline Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nicergoline Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Nicergoline Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Nicergoline market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Nicergoline is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Nicergoline is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Nicergoline is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Nicergoline include Shandong Qidu Pharmaceutical Co. Ltd., Shandong Fangming Pharmaceutical Group Co. Ltd., Pfizer Pharmaceutical Co., Ltd., Hebei Lingding Biotechnology Co., Ltd., Hainan Zambon Pharmaceutical Co. Ltd, Hainan General Kangli Pharmaceutical Co. Ltd., Hainan Poly Pharm Co. Ltd, Fengchen and Tocris Bioscience, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Nicergoline market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Nicergoline Market by Company

Shandong Qidu Pharmaceutical Co. Ltd.

Shandong Fangming Pharmaceutical Group Co. Ltd.

Pfizer Pharmaceutical Co., Ltd.

Hebei Lingding Biotechnology Co., Ltd.

Hainan Zambon Pharmaceutical Co. Ltd

Hainan General Kangli Pharmaceutical Co. Ltd.

Hainan Poly Pharm Co. Ltd

Fengchen

Tocris Bioscience

Teva API

Solarium Pharmaceuticals

Selleck Chemicals

Pharmacia

Olon Group

LGC

Kunshan Rotam Reddy Pharmaceutical Co. Ltd.

Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd.

FAREVA

DEAFARMA

Nicergoline Segment by Type

For Injection

For Oral

Nicergoline Segment by Application

Alzheimer's Disease (AD)

Arterial Hypertension

Cerebral Thrombosis

Others

Nicergoline Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicergoline market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nicergoline and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicergoline.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Nicergoline manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Nicergoline by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Nicergoline in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Nicergoline Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Nicergoline Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Nicergoline Sales Market Share by Manufacturers (2021-2026) Table 8. Global Nicergoline Revenue of Manufacturers (2021-2026) Table 9. Global Nicergoline Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Nicergoline Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Nicergoline Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Nicergoline, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Nicergoline, Product Type & Application Table 14. Global Nicergoline Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Nicergoline by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Shandong Qidu Pharmaceutical Co. Ltd. Company Information Table 19. Shandong Qidu Pharmaceutical Co. Ltd. Business Overview Table 20. Shandong Qidu Pharmaceutical Co. Ltd. Nicergoline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Shandong Qidu Pharmaceutical Co. Ltd. Nicergoline Product Portfolio Table 22. Shandong Qidu Pharmaceutical Co. Ltd. Recent Developments Table 23. Shandong Fangming Pharmaceutical Group Co. Ltd. Company Information Table 24. Shandong Fangming Pharmaceutical Group Co. Ltd. Business Overview Table 25. Shandong Fangming Pharmaceutical Group Co. Ltd. Nicergoline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Shandong Fangming Pharmaceutical Group Co. Ltd. Nicergoline Product Portfolio Table 27. Shandong Fangming Pharmaceutical Group Co. Ltd. Recent Developments Table 28. Pfizer Pharmaceutical Co., Ltd. Company Information Table 29. Pfizer Pharmaceutical Co., Ltd. Business Overview Table 30. Pfizer Pharmaceutical Co., Ltd. Nicergoline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Pfizer Pharmaceutical Co., Ltd. Nicergoline Product Portfolio Table 32. Pfizer Pharmaceutical Co., Ltd. Recent Developments Table 33. Hebei Lingding Biotechnology Co., Ltd. Company Information Table 34. Hebei Lingding Biotechnology Co., Ltd. Business Overview Table 35. Hebei Lingding Biotechnology Co., Ltd. Nicergoline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Hebei Lingding Biotechnology Co., Ltd. Nicergoline Product Portfolio Table 37. Hebei Lingding Biotechnology Co., Ltd. Recent Developments Table 38. Hainan Zambon Pharmaceutical Co. Ltd Company Information Table 39. Hainan Zambon Pharmaceutical Co. Ltd Business Overview Table 40. Hainan Zambon Pharmaceutical Co. Ltd Nicergoline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Hainan Zambon Pharmaceutical Co. Ltd Nicergoline Product Portfolio Table 42. Hainan Zambon Pharmaceutical Co. Ltd Recent Developments Table 43. Hainan General Kangli Pharmaceutical Co. Ltd. Company Information Table 44. Hainan General Kangli Pharmaceutical Co. Ltd. Business Overview Table 45. Hainan General Kangli Pharmaceutical Co. Ltd. Nicergoline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Hainan General Kangli Pharmaceutical Co. Ltd. Nicergoline Product Portfolio Table 47. Hainan General Kangli Pharmaceutical Co. Ltd. Recent Developments Table 48. Hainan Poly Pharm Co. Ltd Company Information Table 49. Hainan Poly Pharm Co. Ltd Business Overview Table 50. Hainan Poly Pharm Co. Ltd Nicergoline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Hainan Poly Pharm Co. Ltd Nicergoline Product Portfolio Table 52. Hainan Poly Pharm Co. Ltd Recent Developments Table 53. Fengchen Company Information Table 54. Fengchen Business Overview Table 55. Fengchen Nicergoline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Fengchen Nicergoline Product Portfolio Table 57. Fengchen Recent Developments Table 58. Tocris Bioscience Company Information Table 59. Tocris Bioscience Business Overview Table 60. Tocris Bioscience Nicergoline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Tocris Bioscience Nicergoline Product Portfolio Table 62. Tocris Bioscience Recent Developments Table 63. Teva API Company Information Table 64. Teva API Business Overview Table 65. Teva API Nicergoline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Teva API Nicergoline Product Portfolio Table 67. Teva API Recent Developments Table 68. Solarium Pharmaceuticals Company Information Table 69. Solarium Pharmaceuticals Business Overview Table 70. Solarium Pharmaceuticals Nicergoline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Solarium Pharmaceuticals Nicergoline Product Portfolio Table 72. Solarium Pharmaceuticals Recent Developments Table 73. Selleck Chemicals Company Information Table 74. Selleck Chemicals Business Overview Table 75. Selleck Chemicals Nicergoline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Selleck Chemicals Nicergoline Product Portfolio Table 77. Selleck Chemicals Recent Developments Table 78. Pharmacia Company Information Table 79. Pharmacia Business Overview Table 80. Pharmacia Nicergoline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Pharmacia Nicergoline Product Portfolio Table 82. Pharmacia Recent Developments Table 83. Olon Group Company Information Table 84. Olon Group Business Overview Table 85. Olon Group Nicergoline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Olon Group Nicergoline Product Portfolio Table 87. Olon Group Recent Developments Table 88. LGC Company Information Table 89. LGC Business Overview Table 90. LGC Nicergoline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. LGC Nicergoline Product Portfolio Table 92. LGC Recent Developments Table 93. Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Company Information Table 94. Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Business Overview Table 95. Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Nicergoline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Nicergoline Product Portfolio Table 97. Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Recent Developments Table 98. Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Company Information Table 99. Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Business Overview Table 100. Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Nicergoline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Nicergoline Product Portfolio Table 102. Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Recent Developments Table 103. FAREVA Company Information Table 104. FAREVA Business Overview Table 105. FAREVA Nicergoline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. FAREVA Nicergoline Product Portfolio Table 107. FAREVA Recent Developments Table 108. DEAFARMA Company Information Table 109. DEAFARMA Business Overview Table 110. DEAFARMA Nicergoline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. DEAFARMA Nicergoline Product Portfolio Table 112. DEAFARMA Recent Developments Table 113. Global Nicergoline Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 114. Global Nicergoline Sales by Region (2021-2026) & (K Units) Table 115. Global Nicergoline Sales Market Share by Region (2021-2026) Table 116. Global Nicergoline Sales by Region (2027-2032) & (K Units) Table 117. Global Nicergoline Sales Market Share by Region (2027-2032) Table 118. Global Nicergoline Revenue by Region (2021-2026) & (US$ Million) Table 119. Global Nicergoline Revenue Market Share by Region (2021-2026) Table 120. Global Nicergoline Revenue by Region (2027-2032) & (US$ Million) Table 121. Global Nicergoline Revenue Market Share by Region (2027-2032) Table 122. North America Nicergoline Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. North America Nicergoline Sales by Country (2021-2026) & (K Units) Table 124. North America Nicergoline Sales by Country (2027-2032) & (K Units) Table 125. North America Nicergoline Revenue by Country (2021-2026) & (US$ Million) Table 126. North America Nicergoline Revenue by Country (2027-2032) & (US$ Million) Table 127. Europe Nicergoline Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Europe Nicergoline Sales by Country (2021-2026) & (K Units) Table 129. Europe Nicergoline Sales by Country (2027-2032) & (K Units) Table 130. Europe Nicergoline Revenue by Country (2021-2026) & (US$ Million) Table 131. Europe Nicergoline Revenue by Country (2027-2032) & (US$ Million) Table 132. Asia Pacific Nicergoline Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Asia Pacific Nicergoline Sales by Country (2021-2026) & (K Units) Table 134. Asia Pacific Nicergoline Sales by Country (2027-2032) & (K Units) Table 135. Asia Pacific Nicergoline Revenue by Country (2021-2026) & (US$ Million) Table 136. Asia Pacific Nicergoline Revenue by Country (2027-2032) & (US$ Million) Table 137. South America Nicergoline Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. South America Nicergoline Sales by Country (2021-2026) & (K Units) Table 139. South America Nicergoline Sales by Country (2027-2032) & (K Units) Table 140. South America Nicergoline Revenue by Country (2021-2026) & (US$ Million) Table 141. South America Nicergoline Revenue by Country (2027-2032) & (US$ Million) Table 142. Middle East and Africa Nicergoline Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. Middle East and Africa Nicergoline Sales by Country (2021-2026) & (K Units) Table 144. Middle East and Africa Nicergoline Sales by Country (2027-2032) & (K Units) Table 145. Middle East and Africa Nicergoline Revenue by Country (2021-2026) & (US$ Million) Table 146. Middle East and Africa Nicergoline Revenue by Country (2027-2032) & (US$ Million) Table 147. Global Nicergoline Sales by Type (2021-2026) & (K Units) Table 148. Global Nicergoline Sales by Type (2027-2032) & (K Units) Table 149. Global Nicergoline Sales Market Share by Type (2021-2026) Table 150. Global Nicergoline Sales Market Share by Type (2027-2032) Table 151. Global Nicergoline Revenue by Type (2021-2026) & (US$ Million) Table 152. Global Nicergoline Revenue by Type (2027-2032) & (US$ Million) Table 153. Global Nicergoline Revenue Market Share by Type (2021-2026) Table 154. Global Nicergoline Revenue Market Share by Type (2027-2032) Table 155. Global Nicergoline Price by Type (2021-2026) & (US$/Unit) Table 156. Global Nicergoline Price by Type (2027-2032) & (US$/Unit) Table 157. Global Nicergoline Sales by Application (2021-2026) & (K Units) Table 158. Global Nicergoline Sales by Application (2027-2032) & (K Units) Table 159. Global Nicergoline Sales Market Share by Application (2021-2026) Table 160. Global Nicergoline Sales Market Share by Application (2027-2032) Table 161. Global Nicergoline Revenue by Application (2021-2026) & (US$ Million) Table 162. Global Nicergoline Revenue by Application (2027-2032) & (US$ Million) Table 163. Global Nicergoline Revenue Market Share by Application (2021-2026) Table 164. Global Nicergoline Revenue Market Share by Application (2027-2032) Table 165. Global Nicergoline Price by Application (2021-2026) & (US$/Unit) Table 166. Global Nicergoline Price by Application (2027-2032) & (US$/Unit) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Nicergoline Distributors List Table 170. Nicergoline Customers List Table 171. Nicergoline Industry Trends Table 172. Nicergoline Industry Drivers Table 173. Nicergoline Industry Restraints Table 174. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Nicergoline Product Image Figure 5. Global Nicergoline Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Nicergoline Market Size (2021-2032) & (US$ Million) Figure 7. Global Nicergoline Sales (2021-2032) & (K Units) Figure 8. Global Nicergoline Average Price (US$/Unit) & (2021-2032) Figure 9. For Injection Product Image Figure 10. For Oral Product Image Figure 11. Alzheimer's Disease (AD) Product Image Figure 12. Arterial Hypertension Product Image Figure 13. Cerebral Thrombosis Product Image Figure 14. Others Product Image Figure 15. Global Nicergoline Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Nicergoline, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Nicergoline Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Nicergoline Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Nicergoline Sales by Region in 2025 Figure 21. Global Nicergoline Revenue by Region in 2025 Figure 22. North America Nicergoline Market Size by Country in 2025 Figure 23. North America Nicergoline Sales Market Share by Country (2021-2032) Figure 24. North America Nicergoline Revenue Market Share by Country (2021-2032) Figure 25. United States Nicergoline Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Nicergoline Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Nicergoline Market Size by Country in 2025 Figure 28. Europe Nicergoline Sales Market Share by Country (2021-2032) Figure 29. Europe Nicergoline Revenue Market Share by Country (2021-2032) Figure 30. Germany Nicergoline Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Nicergoline Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Nicergoline Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Nicergoline Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Netherlands Nicergoline Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Asia Pacific Nicergoline Market Size by Country in 2025 Figure 36. Asia Pacific Nicergoline Sales Market Share by Country (2021-2032) Figure 37. Asia Pacific Nicergoline Revenue Market Share by Country (2021-2032) Figure 38. China Nicergoline Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Japan Nicergoline Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. South Korea Nicergoline Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. India Nicergoline Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Australia Nicergoline Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. China Taiwan Nicergoline Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Southeast Asia Nicergoline Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Southeast Asia Nicergoline Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South America Nicergoline Market Size by Country in 2025 Figure 47. South America Nicergoline Sales Market Share by Country (2021-2032) Figure 48. South America Nicergoline Revenue Market Share by Country (2021-2032) Figure 49. Mexico Nicergoline Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Brazil Nicergoline Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Argentina Nicergoline Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Middle East and Africa Nicergoline Market Size by Country in 2025 Figure 53. Middle East and Africa Nicergoline Sales Market Share by Country (2021-2032) Figure 54. Middle East and Africa Nicergoline Revenue Market Share by Country (2021-2032) Figure 55. Turkey Nicergoline Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Saudi Arabia Nicergoline Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. UAE Nicergoline Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Global Nicergoline Sales Market Share by Type (2021-2032) Figure 59. Global Nicergoline Revenue Market Share by Type (2021-2032) Figure 60. Global Nicergoline Price (US$/Unit) by Type (2021-2032) Figure 61. Global Nicergoline Sales Market Share by Application (2021-2032) Figure 62. Global Nicergoline Revenue Market Share by Application (2021-2032) Figure 63. Global Nicergoline Price (US$/Unit) by Application (2021-2032) Figure 64. Nicergoline Value Chain Figure 65. Nicergoline Production Mode & Process Figure 66. Direct Comparison with Distribution Share Figure 67. Distributors Profiles Figure 68. Nicergoline Industry Opportunities and Challenges

Scope & coverage.

Types
  • For Injection
  • For Oral
Applications
  • Alzheimer's Disease (AD)
  • Arterial Hypertension
  • Cerebral Thrombosis
  • Others
Companies covered
  • Shandong Qidu Pharmaceutical Co. Ltd.
  • Shandong Fangming Pharmaceutical Group Co. Ltd.
  • Pfizer Pharmaceutical Co., Ltd.
  • Hebei Lingding Biotechnology Co., Ltd.
  • Hainan Zambon Pharmaceutical Co. Ltd
  • Hainan General Kangli Pharmaceutical Co. Ltd.
  • Hainan Poly Pharm Co. Ltd
  • Fengchen
  • Tocris Bioscience
  • Teva API
  • Solarium Pharmaceuticals
  • Selleck Chemicals
  • Pharmacia
  • Olon Group
  • LGC
  • Kunshan Rotam Reddy Pharmaceutical Co. Ltd.
  • Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd.
  • FAREVA
  • DEAFARMA

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Nicergoline Market Size (2021-2032)
  4. 2.2.2 Global Nicergoline Sales (2021-2032)
  5. 2.2.3 Global Nicergoline Market Average Price (2021-2032)
  6. 2.3 Nicergoline by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 For Injection
  9. 2.3.3 For Oral
  10. 2.4 Nicergoline by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Alzheimer's Disease (AD)
  13. 2.4.3 Arterial Hypertension
  14. 2.4.4 Cerebral Thrombosis
  15. 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Nicergoline Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Nicergoline Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Nicergoline Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Nicergoline Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Nicergoline Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Nicergoline, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Nicergoline, Product Type & Application
  8. 3.8 Global Manufacturers of Nicergoline, Established Date
  9. 3.9 Global Nicergoline Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Shandong Qidu Pharmaceutical Co. Ltd.
  2. 4.1.1 Shandong Qidu Pharmaceutical Co. Ltd. Company Information
  3. 4.1.2 Shandong Qidu Pharmaceutical Co. Ltd. Business Overview
  4. 4.1.3 Shandong Qidu Pharmaceutical Co. Ltd. Nicergoline Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Shandong Qidu Pharmaceutical Co. Ltd. Nicergoline Product Portfolio
  6. 4.1.5 Shandong Qidu Pharmaceutical Co. Ltd. Recent Developments
  7. 4.2 Shandong Fangming Pharmaceutical Group Co. Ltd.
  8. 4.2.1 Shandong Fangming Pharmaceutical Group Co. Ltd. Company Information
  9. 4.2.2 Shandong Fangming Pharmaceutical Group Co. Ltd. Business Overview
  10. 4.2.3 Shandong Fangming Pharmaceutical Group Co. Ltd. Nicergoline Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Shandong Fangming Pharmaceutical Group Co. Ltd. Nicergoline Product Portfolio
  12. 4.2.5 Shandong Fangming Pharmaceutical Group Co. Ltd. Recent Developments
  13. 4.3 Pfizer Pharmaceutical Co., Ltd.
  14. 4.3.1 Pfizer Pharmaceutical Co., Ltd. Company Information
  15. 4.3.2 Pfizer Pharmaceutical Co., Ltd. Business Overview
  16. 4.3.3 Pfizer Pharmaceutical Co., Ltd. Nicergoline Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Pfizer Pharmaceutical Co., Ltd. Nicergoline Product Portfolio
  18. 4.3.5 Pfizer Pharmaceutical Co., Ltd. Recent Developments
  19. 4.4 Hebei Lingding Biotechnology Co., Ltd.
  20. 4.4.1 Hebei Lingding Biotechnology Co., Ltd. Company Information
  21. 4.4.2 Hebei Lingding Biotechnology Co., Ltd. Business Overview
  22. 4.4.3 Hebei Lingding Biotechnology Co., Ltd. Nicergoline Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Hebei Lingding Biotechnology Co., Ltd. Nicergoline Product Portfolio
  24. 4.4.5 Hebei Lingding Biotechnology Co., Ltd. Recent Developments
  25. 4.5 Hainan Zambon Pharmaceutical Co. Ltd
  26. 4.5.1 Hainan Zambon Pharmaceutical Co. Ltd Company Information
  27. 4.5.2 Hainan Zambon Pharmaceutical Co. Ltd Business Overview
  28. 4.5.3 Hainan Zambon Pharmaceutical Co. Ltd Nicergoline Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Hainan Zambon Pharmaceutical Co. Ltd Nicergoline Product Portfolio
  30. 4.5.5 Hainan Zambon Pharmaceutical Co. Ltd Recent Developments
  31. 4.6 Hainan General Kangli Pharmaceutical Co. Ltd.
  32. 4.6.1 Hainan General Kangli Pharmaceutical Co. Ltd. Company Information
  33. 4.6.2 Hainan General Kangli Pharmaceutical Co. Ltd. Business Overview
  34. 4.6.3 Hainan General Kangli Pharmaceutical Co. Ltd. Nicergoline Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Hainan General Kangli Pharmaceutical Co. Ltd. Nicergoline Product Portfolio
  36. 4.6.5 Hainan General Kangli Pharmaceutical Co. Ltd. Recent Developments
  37. 4.7 Hainan Poly Pharm Co. Ltd
  38. 4.7.1 Hainan Poly Pharm Co. Ltd Company Information
  39. 4.7.2 Hainan Poly Pharm Co. Ltd Business Overview
  40. 4.7.3 Hainan Poly Pharm Co. Ltd Nicergoline Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Hainan Poly Pharm Co. Ltd Nicergoline Product Portfolio
  42. 4.7.5 Hainan Poly Pharm Co. Ltd Recent Developments
  43. 4.8 Fengchen
  44. 4.8.1 Fengchen Company Information
  45. 4.8.2 Fengchen Business Overview
  46. 4.8.3 Fengchen Nicergoline Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Fengchen Nicergoline Product Portfolio
  48. 4.8.5 Fengchen Recent Developments
  49. 4.9 Tocris Bioscience
  50. 4.9.1 Tocris Bioscience Company Information
  51. 4.9.2 Tocris Bioscience Business Overview
  52. 4.9.3 Tocris Bioscience Nicergoline Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Tocris Bioscience Nicergoline Product Portfolio
  54. 4.9.5 Tocris Bioscience Recent Developments
  55. 4.10 Teva API
  56. 4.10.1 Teva API Company Information
  57. 4.10.2 Teva API Business Overview
  58. 4.10.3 Teva API Nicergoline Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Teva API Nicergoline Product Portfolio
  60. 4.10.5 Teva API Recent Developments
  61. 4.11 Solarium Pharmaceuticals
  62. 4.11.1 Solarium Pharmaceuticals Company Information
  63. 4.11.2 Solarium Pharmaceuticals Business Overview
  64. 4.11.3 Solarium Pharmaceuticals Nicergoline Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Solarium Pharmaceuticals Nicergoline Product Portfolio
  66. 4.11.5 Solarium Pharmaceuticals Recent Developments
  67. 4.12 Selleck Chemicals
  68. 4.12.1 Selleck Chemicals Company Information
  69. 4.12.2 Selleck Chemicals Business Overview
  70. 4.12.3 Selleck Chemicals Nicergoline Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Selleck Chemicals Nicergoline Product Portfolio
  72. 4.12.5 Selleck Chemicals Recent Developments
  73. 4.13 Pharmacia
  74. 4.13.1 Pharmacia Company Information
  75. 4.13.2 Pharmacia Business Overview
  76. 4.13.3 Pharmacia Nicergoline Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Pharmacia Nicergoline Product Portfolio
  78. 4.13.5 Pharmacia Recent Developments
  79. 4.14 Olon Group
  80. 4.14.1 Olon Group Company Information
  81. 4.14.2 Olon Group Business Overview
  82. 4.14.3 Olon Group Nicergoline Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Olon Group Nicergoline Product Portfolio
  84. 4.14.5 Olon Group Recent Developments
  85. 4.15 LGC
  86. 4.15.1 LGC Company Information
  87. 4.15.2 LGC Business Overview
  88. 4.15.3 LGC Nicergoline Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 LGC Nicergoline Product Portfolio
  90. 4.15.5 LGC Recent Developments
  91. 4.16 Kunshan Rotam Reddy Pharmaceutical Co. Ltd.
  92. 4.16.1 Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Company Information
  93. 4.16.2 Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Business Overview
  94. 4.16.3 Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Nicergoline Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Nicergoline Product Portfolio
  96. 4.16.5 Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Recent Developments
  97. 4.17 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd.
  98. 4.17.1 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Company Information
  99. 4.17.2 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Business Overview
  100. 4.17.3 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Nicergoline Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Nicergoline Product Portfolio
  102. 4.17.5 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Recent Developments
  103. 4.18 FAREVA
  104. 4.18.1 FAREVA Company Information
  105. 4.18.2 FAREVA Business Overview
  106. 4.18.3 FAREVA Nicergoline Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 FAREVA Nicergoline Product Portfolio
  108. 4.18.5 FAREVA Recent Developments
  109. 4.19 DEAFARMA
  110. 4.19.1 DEAFARMA Company Information
  111. 4.19.2 DEAFARMA Business Overview
  112. 4.19.3 DEAFARMA Nicergoline Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 DEAFARMA Nicergoline Product Portfolio
  114. 4.19.5 DEAFARMA Recent Developments
5 Global Nicergoline Market Scenario by Region
  1. 5.1 Global Nicergoline Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Nicergoline Sales by Region: 2021-2032
  3. 5.2.1 Global Nicergoline Sales by Region: 2021-2026
  4. 5.2.2 Global Nicergoline Sales by Region: 2027-2032
  5. 5.3 Global Nicergoline Revenue by Region: 2021-2032
  6. 5.3.1 Global Nicergoline Revenue by Region: 2021-2026
  7. 5.3.2 Global Nicergoline Revenue by Region: 2027-2032
  8. 5.4 North America Nicergoline Market Facts & Figures by Country
  9. 5.4.1 North America Nicergoline Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Nicergoline Sales by Country (2021-2032)
  11. 5.4.3 North America Nicergoline Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Nicergoline Market Facts & Figures by Country
  15. 5.5.1 Europe Nicergoline Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Nicergoline Sales by Country (2021-2032)
  17. 5.5.3 Europe Nicergoline Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Nicergoline Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Nicergoline Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Nicergoline Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Nicergoline Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Nicergoline Market Facts & Figures by Country
  35. 5.7.1 South America Nicergoline Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Nicergoline Sales by Country (2021-2032)
  37. 5.7.3 South America Nicergoline Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Nicergoline Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Nicergoline Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Nicergoline Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Nicergoline Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Nicergoline Sales by Type (2021-2032)
  2. 6.1.1 Global Nicergoline Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Nicergoline Sales Market Share by Type (2021-2032)
  4. 6.2 Global Nicergoline Revenue by Type (2021-2032)
  5. 6.2.1 Global Nicergoline Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Nicergoline Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Nicergoline Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Nicergoline Sales by Application (2021-2032)
  2. 7.1.1 Global Nicergoline Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Nicergoline Sales Market Share by Application (2021-2032)
  4. 7.2 Global Nicergoline Revenue by Application (2021-2032)
  5. 7.2.1 Global Nicergoline Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Nicergoline Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Nicergoline Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Nicergoline Value Chain Analysis
  2. 8.1.1 Nicergoline Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Nicergoline Production Mode & Process
  5. 8.2 Nicergoline Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Nicergoline Distributors
  8. 8.2.3 Nicergoline Customers
9 Global Nicergoline Analyzing Market Dynamics
  1. 9.1 Nicergoline Industry Trends
  2. 9.2 Nicergoline Industry Drivers
  3. 9.3 Nicergoline Industry Opportunities and Challenges
  4. 9.4 Nicergoline Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst